session.ipcountry = 30
Email
Password
Remember me
Forgotten password?
A Phase III trial to evaluate the safety and efficacy of E 5564 (eritoran), from Eisai, in reducing mortality in patients with severe Sepsis...
BTG disclosed top-line results from a Phase IIb study conducted by AstraZeneca which had compared two doses of CytoFab (polyclonal ovine...
Xigris(drotrecogin alfa (activated)) from Eli Lilly ,which was first approved in the USA in 2001 and in the EU in 2002, is now withdrawn in...
